Market Value2,101,757,147
Total Holdings68
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ADCT / ADC Therapeutics SA
FATE / Fate Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
ZBH / Zimmer Biomet Holdings, Inc.
IGMS / IGM Biosciences, Inc.
XERS / Xeris Biopharma Holdings, Inc.
PEN / Penumbra, Inc.
ZYME / Zymeworks Inc.
NRIX / Nurix Therapeutics, Inc.
ANNX / Annexon, Inc.
KRYS / Krystal Biotech, Inc.
FOLD / Amicus Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
AKRO / Akero Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
ALVR / AlloVir, Inc.
EVH / Evolent Health, Inc.
HCA / HCA Healthcare, Inc.
RGNX / REGENXBIO Inc.
CLDX / Celldex Therapeutics, Inc.
ETNB / 89bio, Inc.
ELV / Elevance Health, Inc.
TKNO / Alpha Teknova, Inc.
LSAQ / LifeSci Acquisition II Corp
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
NUVB / Nuvation Bio Inc.
CABA / Cabaletta Bio, Inc.
ATRA / Atara Biotherapeutics, Inc.
SONX / Sonendo, Inc.
ABSI / Absci Corporation
STTK / Shattuck Labs, Inc.
SYK / Stryker Corporation
AUGX / Augmedix, Inc.
NLTX / Neoleukin Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
US64049K2033 / Neoleukin Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
IQV / IQVIA Holdings Inc.
SLRN / Acelyrin, Inc.
STVN / Stevanato Group S.p.A.
XENE / Xenon Pharmaceuticals Inc.
CUTR / Cutera, Inc.
DXCM / DexCom, Inc.
HUM / Humana Inc.
MDVLQ / MedAvail Holdings, Inc.
REPL / Replimune Group, Inc.
BEAM / Beam Therapeutics Inc.
VTYX / Ventyx Biosciences, Inc.
NVTA / Invitae Corporation
JAZZ / Jazz Pharmaceuticals plc
SLGC / Standard BioTools Inc.
BHVN / Biohaven Ltd.
RYZB / RayzeBio, Inc.
LVTX / LAVA Therapeutics N.V.
VERV / Verve Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
CTLT / Catalent, Inc.
CRL / Charles River Laboratories International, Inc.
ALLK / Allakos Inc.
IVVD / Invivyd, Inc.
BCEL / Atreca, Inc.
PLRX / Pliant Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
RAPT / RAPT Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
BSX / Boston Scientific Corporation
STXS / Stereotaxis, Inc.
COGT / Cogent Biosciences, Inc.
STOK / Stoke Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
LIVN / LivaNova PLC
SRRK / Scholar Rock Holding Corporation
GRTSQ / Gritstone bio, Inc.
IMVT / Immunovant, Inc.
PRME / Prime Medicine, Inc.